MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Alphatec Holdings Operating Income 2011-2026 | ATEC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.1 M | -136 M | -173 M | -147 M | -128 M | -58.9 M | -47.3 M | -22.4 M | -9 M | -15.4 M | -176 M | 1.48 M | -73.4 M | -9.84 M | -24.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 M | -176 M | -73.5 M |
Quarterly Operating Income Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.1 M | -44.3 M | - | -33.7 M | -35.3 M | -43.3 M | - | -38.4 M | -49.9 M | -40.3 M | - | -35 M | -35.7 M | -41.2 M | - | -35.1 M | -35.8 M | -19 M | - | -12.9 M | -11.2 M | -17.8 M | - | -11.6 M | -10.4 M | -10.8 M | - | -7.53 M | -6.54 M | -667 K | - | -1.26 M | -735 K | -3.4 M | - | -4.55 M | -320 K | -3.44 M | - | -165 M | -2.83 M | 1.14 M | - | 1.73 M | 1.84 M | -4.7 M | - | -13.2 M | -2.9 M | -1.36 M | - | -1.97 M | -3.75 M | -126 K | - | -2.36 M | -3.3 M | -2.36 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.84 M | -165 M | -18.2 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 31.12 | -0.34 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 6.82 | 2.95 % | $ 490 M |  Israel |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.44 | 0.58 % | $ 119 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 12.98 | -14.39 % | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 270.55 | 0.41 % | $ 7.63 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 39.83 | -0.15 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 74.69 | 1.66 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.5 | -1.96 % | $ 168 M |  France |
 |
Electromed
ELMD
|
9.66 M | $ 24.17 | 1.05 % | $ 204 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 46.25 | 0.61 % | $ 1.44 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-12.4 M | $ 9.28 | -9.16 % | $ 265 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.91 | -0.39 % | $ 899 M | Israel |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 100.65 | 0.15 % | $ 1.28 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-50 M | $ 75.32 | -3.79 % | $ 2.12 B |  Costa-rica |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.54 | -0.22 % | $ 122 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 70.57 | 0.4 % | $ 3.85 B |  Britain |
 |
Globus Medical
GMED
|
480 M | $ 95.47 | -0.77 % | $ 12.9 B | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 96.23 | -0.44 % | $ 124 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 4.89 | -7.48 % | $ 723 M | USA |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 1.56 | -4.6 % | $ 61 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.91 | -12.07 % | $ 1.16 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |